Pericytes as novel targets for HIV/SIV infection in the lung
Authors:
- 9 September 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 319 (5) , L848-L853
Abstract
Antiretroviral therapy in HIV patients has lengthened lifespan but led to an increased risk for secondary comorbidities, such as pulmonary complications characterized by vascular dysfunction. In the lung, PDGFRβ+ mesenchymal cells known as pericytes intimately associate with endothelial cells and are key for their survival both structurally and through the secretion of prosurvival factors. We hypothesize that in HIV infection there are functional changes in pericytes that may lead to destabilization of the microvasculature and ultimately to pulmonary abnormalities. Our objective in this study was to determine whether lung pericytes could be directly infected with HIV. We leveraged lung samples from macaque lungs with or without SIV infection and normal human lung for in vitro experiments. Pericytes were isolated based on the marker platelet-derived growth factor receptor-β (PDGFRβ). We determined that lung PDGFRβ-positive (PDGFRβ+) pericytes from both macaques and humans express CD4, the primary receptor for SIV/HIV, as well as the major coreceptors CXCR4 and CCR5. We found cells positive for both PDGFRβ and SIV in lungs from infected macaques. Lung pericytes isolated from these animals also harbored detectable SIV. To confirm relevance to human disease, we demonstrated that human lung pericytes are capable of being productively infected by HIV in vitro, with the time course of infection suggesting development of viral latency. In summary, we show for the first time that SIV/HIV directly infects lung pericytes, implicating these cells as a novel target and potential reservoir for the virus in vivo.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL126536)
This publication has 36 references indexed in Scilit:
- Blood–brain barrier pericytes as a target for HIV-1 infectionBrain, 2019
- HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral TherapyAIDS Patient Care and STDs, 2015
- Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapyAIDS, 2011
- Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and PromisesDevelopmental Cell, 2011
- Chronic Obstructive Pulmonary Disease in Patients Who Have HIV InfectionClinics in Chest Medicine, 2007
- Longitudinal Analysis of Simian Immunodeficiency Virus (SIV) Replication in the Lungs: Compartmentalized Regulation of SIVThe Journal of Infectious Diseases, 2006
- Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapyMicrovascular Research, 2006
- Re-emergence of HIV after stopping therapyNature, 1999
- Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapyNature Medicine, 1999
- HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patientsClinical and Experimental Immunology, 1994